Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pregnant persons perceptions and uptake of prenatal RSV vaccine – Minnesota, 2023–2024

8 Mar 2025

Abstract excerpt

BACKGROUND: Respiratory syncytial virus (RSV) vaccine was recommended for use during pregnancy in September 2023. OBJECTIVE: To assess pregnant persons' intentions to receive and evaluate factors associated with RSV vaccine intentions and uptake. STUDY DESIGN: We invited 1999 pregnant persons ≥18 years, between 12 and 30 weeks gestation who had received prenatal care at HealthPartners to complete an online survey...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Impact on Reproduction
Share to Respiratory viral infections research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40056807
DOI: 10.1016/j.vaccine.2025.126958

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pregnant persons perceptions and uptake of prenatal RSV vaccine – Minnesota, 2023–2024PMID 40056807Read ↗

Pregnant women's choices for preventing respiratory syncytial virus (RSV)Semantic proximity Read ↗

COVID-19 vaccine uptake and intention during pregnancy in CanadaSemantic proximity Read ↗

Safety Profile of the Bivalent RSVpreF Vaccine (Abrysvo®) Administered During Pregnancy: An Active Real-World Pharmacovigilance Study in Panama, 2025Semantic proximity Read ↗

COVID-19 Vaccine Acceptance Among Pregnant Women and Mothers of Young Children Results of a Survey in 16 CountriesSemantic proximity Read ↗

COVID-19 vaccine uptake and associated risk factors among first antenatal care attendees in Zambia, 2021-2022: a repeated cross-sectional studySemantic proximity Read ↗

Analysis of uptake, effectiveness and safety of COVID-19 vaccinations in pregnancy using the QResearch® database: research protocol and statistical analysis planSemantic proximity Read ↗

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in InfantsSemantic proximity Read ↗

Understanding COVID-19 vaccine uptake during pregnancy: ‘Hesitance’, knowledge, and evidence-based decision-makingSemantic proximity Read ↗

The Effect of COVID-19 Vaccination and Booster on Maternal-Fetal OutcomesSemantic proximity Read ↗

Beyond Efficacy: Policy, Delivery, and Equity Determinants of Long-Acting Monoclonal Antibody Uptake for Infant RSV Prevention—A WAidid Consensus DocumentSemantic proximity Read ↗

Attitudes to combined RSV and hMPV vaccination in older adultsSemantic proximity Read ↗

COVID-19 Risk Perception and Vaccine Uptake among Pregnant Women in GhanaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.